RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden
RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden
RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
BIBLIOGRAFÍA<br />
68. Harvey JM, Howie AJ, Lee SJ, Newbold KM, Adu D, Michael<br />
J, y cols. Renal biopsy findings in hypertensive patient with<br />
proteinuria. Lancet 340:1435-1436, 1992.<br />
69. Luke RG: Hypertensive nephrosclerosis: pathogenesis and<br />
prevalence. Nephrol Dial Transplant 14:2271-2278, 1999.<br />
70. Egido J: Vasoactive hormones and renal sclerosis. Kidney Int<br />
49: 578-597, 1996.<br />
71. Wardle EN: Renal collagen synthesis and its control.<br />
Nephron 83: 106-110, 1999.<br />
72. Isaka Y, Akagi Y, Ando Y, Tsujie M, Imai E: Cytokines and glomerulosclerosis.<br />
Nephrol Dial Transplant 14: 30-32 1999.<br />
73. Luft FC: Hypertensive nephrosclerosis-a cause of end stage<br />
renal disease ? Nephrol Dial Transplant 15: 1515-1517,<br />
2000.<br />
74. Brown DM, Provoost AP, Daly MJ, Lander ES, Jacob HJ:<br />
Renal disease susceptibility and hypertension are under<br />
independent genetic control in the fawn-hooded rat. Nature<br />
Genet 12: 44-51, 1996.<br />
75. Bergman S, Key BO, Kirk KA, Warnock DG, Rostand SG:<br />
Kidney disease in the first-degree relatives of African-<br />
Americans with hypertensive end-stage renal disease. Am J<br />
Kidney Dis 27: 341-346, 1996.<br />
76. O`Dea DF, Murphy SW, Hefferton D, Parkfrey PS: Higher risk<br />
for renal failure in first-degree relatives of white patients with<br />
end-stage renal disease: A population based study. Am J<br />
Kidney Dis 32: 794-801, 1998.<br />
77. Marcantoni C, Ma L-J, Federspiel C, Fogo AB: Hypertensive<br />
nephrosclerosis in African Americans versus Caucasians.<br />
Kidney Int 62: 172-180, 2002.<br />
78. Hollenberg NK: Renal function in the patient with hypertension.<br />
Med Clin North Am 88: 131-140, 2004.<br />
79. Kincaid-Smith P: Hypothesis: Obesity and the insulin resistance<br />
syndrome play a major role in end-stage renal failure<br />
attributed to hypertension and labelled ‘hypertensive nephrosclerosis’.<br />
J Hypertens 22: 1051-1055, 2004.<br />
80. Andronico G, Ferraro-Monterello R, Mangano MT, Rome M,<br />
Rasputi F, Pinto A, y cols. Insulin resistance and glomerular<br />
haemodynamics and essential hipertensión. Kidney Int 62:<br />
1005-1009, 2002.<br />
81. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V,<br />
Whelton PK, y cols. Insulin resistance and risk of chronic<br />
kidney disease in non-diabetic US adults. J Am Soc Nephrol<br />
14: 469-477, 2003.<br />
82. Bloch MJ, Basile J: The diagnosis and management of renovascular<br />
disease: a primary care perspective. Part I. Making<br />
the diagnosis. J Clin Hypertens 5: 210-218, 2003.<br />
83. Zoccali C, Mallamaci F, Finocchiaro P: Atherosclerotic renal<br />
artery stenosis: epidemiology, cardiovascular outcomes, and<br />
clinical prediction rules. J Am Soc Nephrol 13 (Suppl 3):<br />
S179-S183, 2002.<br />
84. Nally JV, Barton DP: Contemporary approach to diagnosis<br />
and evaluation of renovascular hypertension. Urol Clin<br />
North Am 28: 781-791, 2001.<br />
85. Lerman L, Textor SC: Pathophysiology of ischemic nephropathy.<br />
Urol Clin North Am 28: 793-803, 2001.<br />
86. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes<br />
BM, Mossey RT: Renal vascular disease causing end-stage<br />
renal disease, incidence, clinical correlates, and outcomes:<br />
A 20-year clinical experience. Am J Kidney Dis 24: 622-629,<br />
1994.<br />
87. Murphy TP, Rundback JH, Cooper C, Kiernan MS: Chronic<br />
renal ischemia: implications for cardiovascular disease risk.<br />
J Vasc Interv Radiol 13: 1187-1198, 2002.<br />
88. Modi K, Rao VK: Atheroembolic renal disease. J Am Soc<br />
Nephrol 12: 1781-1787, 2001.<br />
89. Scoble JE: Atherosclerotic nephropathy. Kidney Int Suppl: 56<br />
(Suppl 71): S106-S109; 1999.<br />
90. Coresh J, Astor B, Sarnak MJ: Evidence for increased cardiovascular<br />
disease risk in patients with chronic kidney disease.<br />
Curr Opin Nephrol Hypertens 13: 73-81, 2004<br />
91. Keane WF, Eknoyan G: Proteinuria, albuminuria, risk, assessment,<br />
detection, elimination (PARADE): a position paper of<br />
the National Kidney Foundation. Am J Kidney Dis 33: 1004-<br />
1010, 1999.<br />
92. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS:<br />
Prevalence of chronic kidney disease and decreased kidney<br />
function in the adult US population: Third National Health<br />
and Nutrition Examination Survey. Am J Kidney Dis 41: 1-<br />
12, 2003.<br />
93. McClellan WM, Knight DF, Karp H, Brown WW: Early detection<br />
and treatment of renal disease in hospitalized diabetic<br />
and hypertensive patients: important differences between<br />
practice and published guidelines. Am J Kidney Dis 29: 368-<br />
375, 1997.<br />
94. Locatelli F, Del Vecchio L, Pozzoni P: The importance of<br />
early detection of chronic kidney disease. Nephrol Dial<br />
Transplant 17: S2-S7, 2002.<br />
95. Remuzzi G, Ruggenenti P, Perico N: Chronic renal diseases:<br />
renoprotective benefits of renin-angiotensin system inhibition.<br />
Ann Intern Med 136: 604-615, 2002.<br />
96. Rossert J, Fouqueray B, Jacques Boffa J: Anemia management<br />
and delay of chronic renal failure progression. J Am Soc<br />
Nephrol 14: S173-S177, 2003.<br />
97. Górriz JL, Sancho A, Pallardó LM, Amoedo ML, Martín M,<br />
Sanz P, y cols. Significado pronóstico de la diálisis programada<br />
en pacientes que inician tratamiento sustitutivo renal.<br />
Un estudio multicéntrico español. Nefrología 22: 49-59,<br />
2002.<br />
98. De Francisco ALM, Fernández-Fresnedo G: Llegada tardía a<br />
diálisis como consecuencia de insuficiencia renal no identificada.<br />
Nefrología 22: 95-97, 2002.<br />
99. Levinsky NG: Specialist evaluation in chronic kidney disease:<br />
too little, too late. Ann Intern Med 137: 542-543, 2002.<br />
100. Obrador GT, Arora P, Kausz AT, Ruthazer R, Pereira BJ, Levey<br />
AS: Level of renal function at the initiation of dialysis in the<br />
U.S. end-stage renal disease population. Kidney Int 56:<br />
2227-2235, 1999.<br />
101. United States Renal Data System: Excerpts from the 2000<br />
U.S. Renal Data System Annual Data Report: Atlas of End<br />
Stage Renal Disease in the United States. Am J Kidney Dis<br />
36: S1-S279, 2000.<br />
102. Stengel B, Billon S, van Dijk PCW, Jager KJ, Dekker FW,<br />
Simpson K, y cols. on behalf of the ERA-EDTA Registry<br />
Committee: Trends in the incidence of renal replacement<br />
therapy for end-stage renal disease in Europe, 1990-1999.<br />
Nephrol Dial Transplant 18: 1824-1833, 2003.<br />
103. Amenábar JJ, García F, Robles NR, Saracho R, Pinilla J,<br />
Gentil MA, y cols. Informe de diálisis y trasplante de la<br />
Sociedad Española de Nefrología y Registros Autonómicos,<br />
año 2000. Nefrología 22: 310-317, 2002.<br />
189